Hypoxic dose, intensity distribution, and fatigue monitoring are paramount for "live high-train low" effectiveness
Résumé
This article is a comment on: Endurance, aerobic high-intensity, and
repeated sprint cycling performance is unaffected by normobaric “Live
High-Train Low”: a double-blind placebo-controlled cross-over study,
by Bejder J, Andersen AB, Buchardt R, Larsson TH, Olsen NV,
Nordsborg NB. Eur J Appl Physiol (2017) 117:979–988.
Fichier principal
Brocherie_EJAP17_eproof_Hypoxic dose, intensity distribution, and fatigue monitoring are paramount for LHTL effectiveness.pdf (80.31 Ko)
Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...